|
SLXNW Silexion Therapeutics Corp 2022416 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-3,551,000.00 |
| Balance Sheet |
|
Current Assets
|
$3,741,000.00 |
|
Assets
|
$4,246,000.00 |
|
Current Liabilities
|
$3,976,000.00 |
|
Liabilities
|
$4,202,000.00 |
|
Equity
|
$44,000.00 |
|
Shares Out
|
1179844.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-2,925,000.00 |
|
Investing Cash Flow
|
$-1,000.00 |
| Market Analysis |
Market Cap
|
$23,596.88 |
|
Price
|
$0.02 |
|
BVPS
|
0.04 |
|
PB
|
0.50 |
|
EPS
|
5.17 |
|
FCF
|
$-2,925,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:19 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:02:09 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SLXNW documents filed with the SEC.
SLXNW Filings
Clear
